Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
EY looks at ways pharma can bolster its future supply chains
Fierce Pharma July 18, 2022
The genesis of a small molecule drug is often an international affair. The medication might begin its life at an active pharmaceutical ingredient (API) manufacturing facility in Puerto Rico, then stop off for formulation in the Netherlands before going through packaging steps in Greece, China, Japan or the U.S. Along the way, the production process gobbles up myriad consumables and raw materials from an even more diverse geographic spread.
All told, pharmaceutical supply chains have proven remarkably resilient during the COVID-19 pandemic. Thanks to regulatory flexibility, increased government cooperation and some good old-fashioned industry elbow grease, biopharma has largely avoided disruptions like those plaguing the semiconductor-starved consumer electronics sector.
But that’s not to say drugmakers’ supply chains...
Today's Sponsors
Today's Sponsor